EW — EDWARDS LIFESCIENCES CORP

Ownership history in Bayesian Capital Management, LP  ·  15 quarters on record

This page tracks every 13F SEC filing in which Bayesian Capital Management, LP reported a position in EDWARDS LIFESCIENCES CORP (EW). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.88% (2019 Q4)
Avg. % of fund
0.44%
First filed
2015 Q4
Last filed
2025 Q3
Quarters held
15
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 42,100 +36,701 +679.8% 0.67% $3.3M $77.77
2022 Q1 REDUCED 5,399 -15,201 -73.8% 0.09% $636K $117.72
2020 Q4 REDUCED 20,600 -8,600 -29.5% 0.49% $1.9M $91.23
2020 Q3 ADDED 29,200 +9,500 +48.2% 0.57% $2.3M $79.82
11 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    EW price (monthly, adj. close)

Other funds also holding EW

As of 2025 Q4 — sorted by position size

2Xideas AG 3Y 10.25% Seilern Investment Management Ltd 6.1% Longaeva Partners L.P. 6.04% Nantahala Capital Management, LLC 3Y 7Y 5.07% ORBIMED ADVISORS LLC 3Y 7Y 3.21% WILSON ASSET MANAGEMENT (INTERNATIONAL) PTY LTD 3Y 3.17% Triodos Investment Management BV 3Y 7Y 3.15% Saranac Partners Ltd 3.02% WEDGEWOOD PARTNERS INC 3Y 7Y 2.88% Catalio Capital Management, LP 2.82%
← Back to Bayesian Capital Management, LP Holdings